The process of learning the autogenic training relaxation technique and its benefits on the wellness of people living with HIV.


Journal

BMC complementary medicine and therapies
ISSN: 2662-7671
Titre abrégé: BMC Complement Med Ther
Pays: England
ID NLM: 101761232

Informations de publication

Date de publication:
24 Mar 2022
Historique:
received: 28 09 2020
accepted: 08 03 2022
entrez: 25 3 2022
pubmed: 26 3 2022
medline: 29 3 2022
Statut: epublish

Résumé

Various mind-body practices are used by people living with HIV to promote their general well-being. Among these is autogenic training (AT), a self-guided relaxation technique requiring regular practice for observable benefits. However, little has been written about the process of learning this technique, which is obviously a prerequisite to regular practice. This study therefore aims to describe the process by which people living with HIV learn AT. The study is a descriptive qualitative study using semi-structured interviews and a thematic analysis with a mixed approach. Fourteen participants living with HIV completed sessions to learn autogenic training over a period of 3 months. The process of learning AT was approached through three themes: initiating the learning process, taking ownership of the technique, and observing its benefits on wellness. To initiate learning, participants had to express a need to take action on an aspect of their well-being and their openness to complementary approaches to care. Taking ownership of the technique was facilitated by guidance from the nurse researcher, the participants' personal adaptations to overcome barriers to their practice, regular practice, and rapid observation of its benefits. Finally, the participants reported the observation of benefits on their wellness, including personal development, mainly in terms of the creative self, the essential self, and the coping self. This perception of the technique's benefits was part of the learning process, as it contributed both to the participants' ownership of the technique and to reinforcing their AT practice. People living with HIV see learning AT as a progressive process, in which wellness is a major outcome and a contributing factor in developing a regular practice.

Sections du résumé

BACKGROUND BACKGROUND
Various mind-body practices are used by people living with HIV to promote their general well-being. Among these is autogenic training (AT), a self-guided relaxation technique requiring regular practice for observable benefits. However, little has been written about the process of learning this technique, which is obviously a prerequisite to regular practice. This study therefore aims to describe the process by which people living with HIV learn AT.
METHODS METHODS
The study is a descriptive qualitative study using semi-structured interviews and a thematic analysis with a mixed approach. Fourteen participants living with HIV completed sessions to learn autogenic training over a period of 3 months.
RESULTS RESULTS
The process of learning AT was approached through three themes: initiating the learning process, taking ownership of the technique, and observing its benefits on wellness. To initiate learning, participants had to express a need to take action on an aspect of their well-being and their openness to complementary approaches to care. Taking ownership of the technique was facilitated by guidance from the nurse researcher, the participants' personal adaptations to overcome barriers to their practice, regular practice, and rapid observation of its benefits. Finally, the participants reported the observation of benefits on their wellness, including personal development, mainly in terms of the creative self, the essential self, and the coping self. This perception of the technique's benefits was part of the learning process, as it contributed both to the participants' ownership of the technique and to reinforcing their AT practice.
CONCLUSIONS CONCLUSIONS
People living with HIV see learning AT as a progressive process, in which wellness is a major outcome and a contributing factor in developing a regular practice.

Identifiants

pubmed: 35331226
doi: 10.1186/s12906-022-03557-6
pii: 10.1186/s12906-022-03557-6
pmc: PMC8953141
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

86

Informations de copyright

© 2022. The Author(s).

Références

Psychol Health Med. 2014;19(1):47-58
pubmed: 23458241
Menopause. 2009 Jan-Feb;16(1):60-5
pubmed: 18978640
Evid Based Complement Alternat Med. 2016;2016:5013132
pubmed: 28050191
Am Heart J. 2004 Mar;147(3):E10
pubmed: 14999212
Br J Soc Psychol. 2006 Sep;45(Pt 3):639-56
pubmed: 16984725
Appl Psychophysiol Biofeedback. 2002 Mar;27(1):45-98
pubmed: 12001885
Curr HIV/AIDS Rep. 2011 Dec;8(4):257-68
pubmed: 21822625
HIV Med. 2011 Jan;12(1):22-30
pubmed: 20497251
Complement Ther Med. 2006 Jun;14(2):144-50
pubmed: 16765853
Health Qual Life Outcomes. 2013 Apr 08;11:56
pubmed: 23566318
Health Qual Life Outcomes. 2016 Aug 05;14(1):115
pubmed: 27495166
Implement Sci. 2012 Jun 09;7:53
pubmed: 22682656
AIDS Patient Care STDS. 2013 Sep;27(9):503-10
pubmed: 23991688
Res Nurs Health. 2003 Apr;26(2):102-17
pubmed: 12652607
Psychol Psychother. 2009 Dec;82(Pt 4):403-19
pubmed: 19460239
J Psychosom Res. 2008 Oct;65(4):389-401
pubmed: 18805249
Complement Ther Clin Pract. 2019 Feb;34:116-122
pubmed: 30712714
PLoS One. 2017 Dec 6;12(12):e0187727
pubmed: 29211754
Behav Cogn Psychother. 2015 May;43(3):342-59
pubmed: 24229765
BMC Complement Altern Med. 2014 Feb 10;14:50
pubmed: 24512477
Psychol Rev. 2007 Oct;114(4):843-63
pubmed: 17907866
J Int AIDS Soc. 2014 Feb 18;17:18719
pubmed: 24560338
Qual Life Res. 2013 Feb;22(1):65-73
pubmed: 22286271
Psychol Inq. 2015 Oct 1;26(4):293-314
pubmed: 27087765
J Psychiatr Pract. 2013 Mar;19(2):109-17
pubmed: 23507812
AIDS Behav. 2013 Oct;17(8):2808-15
pubmed: 23299876
Qual Life Res. 2015 Jun;24(6):1407-18
pubmed: 25481725
Int J Qual Health Care. 2007 Dec;19(6):349-57
pubmed: 17872937
J Behav Med. 2005 Jun;28(3):249-56
pubmed: 16015459
AIDS Care. 2012;24(8):963-71
pubmed: 22519889
J Complement Integr Med. 2020 Jul 03;18(1):165-174
pubmed: 32621729
Prim Health Care Res Dev. 2012 Apr;13(2):175-85
pubmed: 21787446
Psychooncology. 2017 May;26(5):686-692
pubmed: 26799620
Health Psychol. 2010 Jul;29(4):374-83
pubmed: 20658824
HIV Med. 2019 Sep;20(8):542-554
pubmed: 31162817
Psychol Health Med. 2011 Aug;16(4):484-9
pubmed: 21749245
Int J Obes (Lond). 2008 Apr;32(4):700-7
pubmed: 18071344
Eur J Cancer Care (Engl). 2002 Jun;11(2):122-30
pubmed: 12099948
J Pediatr. 2017 Apr;183:184-190
pubmed: 28088398
Qual Health Res. 2015 May;25(5):587-8
pubmed: 25829508
BMC Complement Altern Med. 2019 Jun 11;19(1):125
pubmed: 31185970
Psychiatry Clin Neurosci. 1997 Feb;51(1):5-8
pubmed: 9076853
J Pain. 2012 Jul;13(7):704-13
pubmed: 22748803

Auteurs

Maria Pilar Ramirez Garcia (MP)

Faculty of Nursing, Université de Montréal, P. 6128, succ. Centre-Ville, Montréal, QC, H3C 3J7, Canada. pilar.ramirez.garcia@umontreal.ca.
Research Center of the Centre Hospitalier de l'Université de Montréal, P. 6128, succ. Centre-Ville, Montréal, QC, H3C 3J7, Canada. pilar.ramirez.garcia@umontreal.ca.
Quebec Nursing Intervention Research Network (RRISIQ), Quebec, QC, Canada. pilar.ramirez.garcia@umontreal.ca.

Jérôme Leclerc-Loiselle (J)

Faculty of Nursing, Université de Montréal, P. 6128, succ. Centre-Ville, Montréal, QC, H3C 3J7, Canada.

José Côté (J)

Faculty of Nursing, Université de Montréal, P. 6128, succ. Centre-Ville, Montréal, QC, H3C 3J7, Canada.
Research Center of the Centre Hospitalier de l'Université de Montréal, P. 6128, succ. Centre-Ville, Montréal, QC, H3C 3J7, Canada.
Quebec Nursing Intervention Research Network (RRISIQ), Quebec, QC, Canada.

Marie-Josée Brouillette (MJ)

Department of Psychiatry, McGill University, Montréal, QC, Canada.
AIDS and Infectious Disease Network (SIDA-MI), Quebec, Canada.

Réjean Thomas (R)

AIDS and Infectious Disease Network (SIDA-MI), Quebec, Canada.
Clinique médicale l'Actuel, Montréal, Québec, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH